Purchases and Sales Made in Q4 2020 in Inhibikase Therapeutics, Inc. (IKT)
This table provides information about the institutional ownership of Inhibikase Therapeutics, Inc. (IKT) during Q4 2020. The information is specifically focused on institutions that hold shares of Inhibikase Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 10, 2021
Q4 2020
|
Zeke Capital Advisors, LLC
Berwyn, PA |
BUY
|
- |
18.8KNew |
$130K - $186K
|
18.8K
$52.8K
|
|
Feb 12, 2021
Q4 2020
|
Maven Securities LTD
St Helier, Y9 |
BUY
|
- |
11KNew |
$75.9K - $109K
|
11K
$30.9K
|
|
Sep 07, 2021
Q4 2020
|
Newbridge Financial Services Group, Inc.
|
BUY
|
- |
250New |
$1.73K - $2.48K
|
250
$703
|
|
Feb 02, 2021
Q4 2020
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|